Date
2021
Abstract
In recent years, three-dimensional (3D) bioprinting has attracted wide research interest in biomedical engineering and clinical applications. This technology allows for unparalleled architecture control, adaptability and repeatability that can overcome the limits of conventional biofabrication techniques. Along with the emergence of a variety of 3D bioprinting methods, bioinks have also come a long way. From their first developments to support bioprinting requirements, they are now engineered to specific injury sites requirements to mimic native tissue characteristics and to support biofunctionality. Current strategies involve the use of bioinks loaded with cells and biomolecules of interest, without altering their functions, to deliver in situ the elements required to enhance healing/regeneration. The current research and trends in bioink development for 3D bioprinting purposes is overviewed herein.
Supervisor
Description
peer-reviewed The full text of this article will not be available in ULIR until the embargo expires on the 08/04/2022
Publisher
IOP Publishing
Citation
Biofabrication;13 (3)
Collections
Bernal Institute
Show all metadata
Files
Thumbnail Image
Collins_2021_Engineering.pdf
Adobe PDF, 1.92 MB
Keywords
additive manufacturing, 3D bioprinting, bioinks, biomaterials, hydrogels
ULRR Identifiers
https://researchrepository.ul.ie/handle/10344/10078
 https://doi.org/10.34961/5276
Funding code
Funding Information
Portuguese Foundation for Science and Technology, Fundo Europeu de Desenvolvimento Regional (FEDER)
Sustainable Development Goals
External Link
Type
Article
Rights
https://creativecommons.org/licenses/by-nc-sa/1.0/
License